BASTIDE LE CONFORT MEDICAL (BLC.PA) Forecast, Price Target & Analyst Ratings

EPA:BLCFR0000035370

Current stock price

25.05 EUR
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BASTIDE LE CONFORT MEDICAL (BLC.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€40.80
+ 62.87% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 14, 2026

ChartMill Buy Consensus

Rating
77.14%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€40.80
Upside
+ 62.87%
From current price of €25.05 to mean target of €40.80, Based on 7 analyst forecasts
Low
€40.40
Median
€40.80
High
€42.00

Price Target Revisions

1 Month
12.68%
3 Months
11.11%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for BLC.PA. The average price target is 40.8 EUR. This implies a price increase of 62.87% is expected in the next year compared to the current price of 25.05.
The average price target has been revised upward by 11.11% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

BLC Current Analyst RatingBLC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

BLC Historical Analyst RatingsBLC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
77.14%
BLC.PA was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about BLC.PA.
In the previous month the buy percentage consensus was at a similar level.
BLC.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-26PORTZAMPARC BNP PARIBASMaintains Buy -> Buy
2023-08-30Oddo BhfMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 14, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BLC.PA revenue by date.BLC.PA revenue by date.
508.031M
8.48%
461.874M
-9.09%
491.18M
6.35%
516.42M
5.14%
544.21M
5.38%
574.6M
5.58%
687.66M
19.68%
718.41M
4.47%
747.8M
4.09%
775.62M
3.72%
EBITDA
YoY % growth
BLC.PA ebitda by date.BLC.PA ebitda by date.
95.446M
3.74%
89.125M
-6.62%
100.773M
13.07%
108.19M
7.36%
114.65M
5.97%
121.58M
6.04%
N/AN/AN/AN/A
EBIT
YoY % growth
BLC.PA ebit by date.BLC.PA ebit by date.
36.689M
12.58%
33.937M
-7.50%
40.13M
18.25%
44.004M
9.65%
47.231M
7.33%
50.17M
6.22%
N/AN/AN/AN/A
Operating Margin
BLC.PA operating margin by date.BLC.PA operating margin by date.
7.22%7.35%8.17%8.52%8.68%8.73%N/AN/AN/AN/A
EPS
YoY % growth
BLC.PA eps by date.BLC.PA eps by date.
N/A
-1.04%
N/A
-3.30%
N/A
-19.38%
1.84
-12.23%
2.05
11.14%
2.49
21.73%
N/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BLC.PA Yearly Revenue VS EstimatesBLC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
BLC.PA Yearly EPS VS EstimatesBLC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.90%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.03%
Revenue Next 5 Year
7.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
38.82%
EBIT Next 5 Year
N/A

BASTIDE LE CONFORT MEDICAL / BLC.PA Forecast FAQ

Can you provide the average price target for BASTIDE LE CONFORT MEDICAL stock?

7 analysts have analysed BLC.PA and the average price target is 40.8 EUR. This implies a price increase of 62.87% is expected in the next year compared to the current price of 25.05.

Can you provide the upcoming earnings date for BASTIDE LE CONFORT MEDICAL?

BASTIDE LE CONFORT MEDICAL (BLC.PA) will report earnings on 2026-05-14.

What is the expected long term growth rate for BASTIDE LE CONFORT MEDICAL (BLC.PA)?

The expected long term growth rate for BASTIDE LE CONFORT MEDICAL (BLC.PA) is 5.03%.